Literature DB >> 2069876

Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique.

C D Collins1, R W Lloyd-Davies, A V Swan.   

Abstract

The survival of 232 patients with apparently localized carcinoma of the prostate is reported, who were treated between October 1964 and October 1984 by a radical course of external beam radiotherapy using a hypofractionation technique. Assessment was made in a retrospective analysis, noting influence of age, stage of disease at presentation, initial histology, dose of radiotherapy given and any subsequent treatment required, recorded up to October 1986. From this it will be seen that the development of a six fraction regime, given over a period of three weeks leads to comparable results to other reported series, whether assessed as a local response or by survival curves, and to the economical use of scarce resources, but even more important, is less wearing for patients than daily fractionation, with early and late morbidity being within acceptable limits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069876     DOI: 10.1016/s0936-6555(05)80831-3

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  17 in total

1.  Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomes.

Authors:  Raymond Miralbell
Journal:  J Radiosurg SBRT       Date:  2011

2.  Tracing the earliest medical uses of high dose-per-fraction external beam radiation.

Authors:  Brian D Kavanagh
Journal:  J Radiosurg SBRT       Date:  2011

Review 3.  The evolution of practical radiobiological modelling.

Authors:  B Jones; R G Dale
Journal:  Br J Radiol       Date:  2018-03-20       Impact factor: 3.039

4.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.

Authors:  Alan Pollack; Alexandra L Hanlon; Eric M Horwitz; Steven J Feigenberg; Andre A Konski; Benjamin Movsas; Richard E Greenberg; Robert G Uzzo; C-M Charlie Ma; Shawn W McNeeley; Mark K Buyyounouski; Robert A Price
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-19       Impact factor: 7.038

5.  Stereotactic body radiotherapy for organ-confined prostate cancer.

Authors:  Alan J Katz; Michael Santoro; Richard Ashley; Ferdinand Diblasio; Matthew Witten
Journal:  BMC Urol       Date:  2010-02-01       Impact factor: 2.264

Review 6.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

7.  Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size.

Authors:  C Bruni; F Conte; F Papa; C Sinisgalli
Journal:  J Math Biol       Date:  2014-08-29       Impact factor: 2.259

Review 8.  Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?

Authors:  Stefano Arcangeli; Carlo Greco
Journal:  Nat Rev Urol       Date:  2016-06-14       Impact factor: 14.432

9.  Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.

Authors:  Mark Ritter
Journal:  Semin Radiat Oncol       Date:  2008-10       Impact factor: 5.934

10.  Hypofractionation for prostate cancer.

Authors:  Mark Ritter; Jeffrey Forman; Patrick Kupelian; Colleen Lawton; Daniel Petereit
Journal:  Cancer J       Date:  2009 Jan-Feb       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.